Fli Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of Fli Antibodies for advanced research in molecular biology. Fli Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fli, or Friend leukemia integration 1, is a transcription factor that plays a vital role in hematopoiesis and the regulation of gene expression during development. The involvement of Fli in cell differentiation and proliferation makes it an essential target for understanding various diseases, including leukemia and other hematological disorders. Research focused on Fli and its interactions provides valuable insights into cancer progression mechanisms and potential therapeutic approaches. Investigating Fli expression patterns helps scientists uncover new pathways in cellular development and disease progression. Understanding the molecular mechanisms of Fli aids in developing targeted treatments for various cancers and blood disorders. Fli Antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of Fli's role in human health and disease.